328
Views
3
CrossRef citations to date
0
Altmetric
Antimicrobial Original Research Paper

The point prevalence and inappropriateness of antibiotic use at hospitals in Turkey: a systematic review and meta-analysis

Pages 390-399 | Received 05 Nov 2020, Accepted 03 Feb 2021, Published online: 23 Feb 2021

References

  • Antimicrobial Stewardship Centers for Disease Control and Prevention, United States of America. Available at: https://www.cdc.gov/antibiotic-use/stewardship-report/hospital.html. Accessed date: 27.03.2020.
  • Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–77.
  • Ansari F, Erntell M, Goossens H, Davey P. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis. 2009;49(10):1496–504.
  • Malcolm W, Nathwani D, Davey P, Cromwell T, Patton A, Reilly J, Cairns S, Bennie M. From intermittent antibiotic point prevalence surveys to quality improvement: experience in Scottish hospitals. Antimicrob Resist Infect Control. 2013;2(1):3–11.
  • Versporten A, Bolokhovets G, Ghazaryan L, Abilova V, Pyshnik G, Spasojevic T, Korinteli I, Raka L, Kambaralieva B, Cizmovic L, et al. Antibiotic use in eastern Europe: A cross-national database study in coordination with the WHO Regional Office for Europe. Lancet Infect Dis. 2014;14(5):381–7.
  • Versporten A, Zarb P, Caniaux I, Gros MF, Drapier N, Miller M, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 2018;6(6):619–29.
  • Robertson J, Iwamoto K, Hoxha I, Ghazaryan L, Abilova V, Cvijanovic A, Pyshnik H, Darakhvelidze M, Makalkina L, Jakupi A, et al. Antimicrobial medicines consumption in Eastern Europeand Central Asia - An Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy Action . Front Pharmacol. 2018;9:1156–69.
  • Hoşoğlu S, Esen S, Ozturk R, Altindis M, Ertek M, Kaygusuz S, Caylan R, Demirdag K, Sencan I, Ertem GT, et al. The effect of a restriction policy on the antimicrobial consumption in Turkey: A country-wide study. Eur J Clin Pharmacol. 2005;61(10):727–31.
  • Stemming the Superbug Tide 2018. Available at: https://www.oecd-ilibrary.org/sites/9789264307599-en/index.html?itemId=/content/publication/9789264307599-en. Accessed date: 27.03.2020.
  • Isler B, Keske Ş, Aksoy M, Azap ÖK, Yilmaz M, Yavuz SŞ, Aygün G, Tigen E, Akalın H, Azap A, et al. Antibiotic overconsumption and resistance in Turkey. Clin Microbiol Infect. 2019;25(6):651–3.
  • Ozkurt Z, Erol S, Kadanali A, Ertek M, Ozden K, Tasyaran MA. Changes in antibiotic use, cost and consumption after an antibiotic restriction policy applied by infectious disease specialists. Jpn J Infect Dis. 2005;58(6):338–43.
  • Arda B, Sipahi OR, Yamazhan T, Tasbakan M, Pullukcu H, Tunger A, Buke C, Ulusoy S. Short-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistance. J Infect. 2007;55(1):41–8.
  • Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6(7):e1000097
  • Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Systematic reviews of prevalence and incidence. In: Aromataris E, Munn Z, editors. Joanna Briggs Institute Reviewer's. Manual: The Joanna Briggs Institute; 2017.
  • WHO Methodology for Point Prevalence Survey on Antibiotic Use in Hospitals Version 1.1. Available at: https://apps.who.int/iris/bitstream/handle/10665/280063/WHO-EMP-IAU-2018.01-eng.pdf?ua=1. Accessed date: 11.10.2020.
  • Hosoglu S, Parlak Z, Geyik MF, Palanci Y. Critical evaluation of antimicrobial use - A Turkish university hospital example. J Infect Dev Ctries. 2013;7(11):873–9.
  • Naz H, Aykin N, Cevik FC. Eskişehir Yunus Emre Devlet Hastanesi’nde yatan hastalarda antibiyotik kullanimina yönelik kesitsel araştirma. ANKEM Derg. 2006;20(3):137–40.
  • Yilmaz GR, Bulut C, Yildiz F. Examining antibiotic use at an education and research hospital in Turkey: Point prevalence results. Turk J Med Sci. 2009;39(1):125–31.
  • Ozgenc O, Genc VE, Ari AA, El S, Sacar S, Ozunlu H, et al. Evaluation of the therapeutic use of antibiotics in Aegean Region hospitals of Turkey: A multicentric study. Indian J Med Microbiol. 2011;29(2):124–9.
  • Devrim I, Gulfidan G, Oruc Y, Yasar N, Sorguc Y, Ayhan FY, et al. Point-prevalence study relating to antibiotic usage in Dr. Behcet Uz Children Hospital point-prevelance study for antibiotics. J Pediatr Inf. 2009;3:11–3.
  • Inan A, Dagli O, Senbayrak AS, Ozturk ED, Karagul E, Ozyurek SC. Antibiotic use and cost in a teaching hospital in İstanbul. J Microbiol Infect Dis. 2011;1(3):128–33.
  • Sozen H, Gönen I, Sözen A, Kutlucan A, Kalemci S, Sahan M. Application of ATC/DDD methodology to evaluate of antibiotic use in a general hospital in Turkey. Ann Clin Microbiol Antimicrob. 2013;12:23–9.
  • Kepenekli E, Soysal A, Yalindag-Ozturk N, Ozgur O, Ozcan I, Devrim I, Akar S, Bakir M, Turkish PICU-HCAI Study Group Healthcare-associated infections in pediatric intensive care units in Turkey: A national point-prevalence survey. Jpn J Infect Dis. 2015;68(5):381–6.
  • Sagmak-Tartar A, Denk A, Ozden M, Celik KY, Akbulut A, Demirdag K. Fırat Üniversitesi Hastanesi’nde antibiyotik kullanımı uygunluğunun araştırılması: Nokta prevalans çalışması. ANKEM Derg. 2015;29(1):16–20.
  • Arlier S, Adiguzel C, Tolunay O, Guzel AB, Saygili YE, Yusel O, et al. Multicenter point prevalence study relating to antibiotic usage in obstetric and gynecology clinics. FLORA. 2015;20(1):30–8.
  • Guclu E, Ogutlu A, Karabay O, Demirdal T, Erayman I, Hosoglu S, Turhan V, Erol S, Oztoprak N, Batirel A, et al. Antibiotic consumption in Turkish hospitals; a multi-centre point prevalence study. J Chemother. 2017;29(1):19–24.
  • Tolunay O, Çelik Ü, Yücel G, Çelik T, Mert MK, Reşitoğlu S, Özdemir U, Narlı N, Hanta D, Yapıcıoğlu H, et al. Antibiotic use in pediatric and neonatal intensive care units; multicenter point prevalence study. J Pediatr Inf. 2014;8(2):56–63.
  • Yilmaz G, Ozturk EM, Ayhan M, Coskun B, Azap A. Evaluation of antibiotic consumption in a university hospital. Klimik Dergisi. 2015;27(3):109–13.
  • Ozturk DB, Kacmaz B, Torun EC, Erol O, Caliskan O, Ecemis K, et al. Antibiotic usage of hospitalised patients in two Hospitals in Kırıkkale: A one day point prevalence study. KÜ Tıp Fak Derg. 2019;21(1):90–4.
  • Ergul AB, Gokcek I, Celik T, Torun YA. Assessment of inappropriate antibiotic use in pediatric patients: Point-prevalence study. Turk Pediatri Ars. 2018;53(1):17–23.
  • Karabay O, Ince N, Aypak A, Guclu E, Bodur H, Group EKMUD Antibiotic Study. Antibiotic usage in hospitalized patients: A one-day point prevalence study. J Chemother. 2020;32(4):188–92.
  • Erdeniz EH, Dursun A. Evaluation of inappropriate antibiotic use in pediatric patients: Point-prevalence study. J Pediatr Inf. 2020;14(2):63–8.
  • Vlahovic-Palcevski V, Morovic M, Palcevski G. Antibiotic utilization at the university hospital after introducing an antibiotic policy. Eur J Clin Pharmacol. 2000;56(1):97–101.
  • Berild D, Ringertz SH, Lelek M. Appropriate antibiotic use according to diagnoses and bacteriological findings: report of 12 point-prevalence studies on antibiotic use in a university hospital. Scand J Infect Dis. 2002;34(1):56–60.
  • Hu S, Liu X, Peng Y. Assessment of antibiotic prescription in hospitalised patients at a Chinese university hospital. J Infect. 2003;46(3):161–3.
  • Mora Y, Avila-Agüero ML, Umaña MA, Jiménez AL, París MM, Faingezicht I. Epidemiological observations of the judicious use of antibiotics in a pediatric teaching hospital. Int J Infect Dis. 2002;6(1):74–7.
  • Parente DM, Morton J. Role of the pharmacist in antimicrobial stewardship. Med Clin North Am. 2018; 102(5):929–36.
  • Magedanz L, Silliprandi EM, dos Santos RP. Impact of the pharmacist on a multidisciplinary team in an antimicrobial stewardship program: A quasi-experimental study. Int J Clin Pharm. 2012;34(2):290–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.